MKDTY — Molecular Data Balance Sheet
0.000.00%
TechnologyHighly SpeculativeMicro Cap
- $0.00m
- -$11.24m
- CNY7.60bn
Annual balance sheet for Molecular Data, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2017 December 31st | 2018 December 31st | 2019 December 31st | 2020 December 31st | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | 20-F | 20-F |
| Standards: | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final |
| Cash and Equivalents | ||||
| Short Term Investments | ||||
| Cash and Short Term Investments | 38.5 | 6.48 | 15.2 | 347 |
| Net Total Accounts Receivable | ||||
| Net Total Receivables | 101 | 62.3 | 211 | 92 |
| Total Inventory | ||||
| Prepaid Expenses | ||||
| Total Other Current Assets | ||||
| Total Current Assets | 376 | 368 | 487 | 663 |
| Gross Property, Plant And Equipment | ||||
| Accumulated Depreciation | ||||
| Net Property, Plant And Equipment | 2.65 | 1.76 | 4.33 | 4.92 |
| Net Intangible Assets | ||||
| Long Term Investments | ||||
| Other Long Term Assets | ||||
| Total Assets | 381 | 372 | 493 | 685 |
| Accounts Payable | ||||
| Payable / Accrued | ||||
| Accrued Expenses | ||||
| Notes Payable / Short Term Debt | ||||
| Current Portion of Long Term Debt / Capital Leases | ||||
| Total Other Current Liabilities | ||||
| Total Current Liabilities | 300 | 255 | 676 | 693 |
| Long Term Debt | ||||
| Capital Lease Obligations | ||||
| Total Long Term Debt | ||||
| Total Debt | ||||
| Minority Interest | ||||
| Total Other Liabilities | ||||
| Total Liabilities | 375 | 433 | 709 | 713 |
| Common Stock | ||||
| Additional Paid In Capital | ||||
| Retained Earnings (Accumulated Deficit) | ||||
| Other Equity | ||||
| Total Equity | 5.9 | -61.6 | -216 | -27.9 |
| Total Liabilities & Shareholders' Equity | 381 | 372 | 493 | 685 |
| Total Common Shares Outstanding |